Recently, it has been demonstrated that β-glucans reduce the expression levels of proinflammatory cytokines such as Tumor necrosis factor-α (TNF-alpha) [33], which is a cytokine that is up-regulated in DMD patients [34], contributing to chronic inflammation during disease progression [35]. Here, TNF is linked to Duchenne muscular dystrophy.